Method for treatment of symptoms of central nervous system disorders
AssigneeMilkaus Laboratory, Inc.
InventorsJohn McMichael, Allan D. Lieberman
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for treating the symptoms of autism comprising the step of administering an effective amount of anti-rubeola antibody.
Claims22
A method of treating the symptoms of autism comprising the step of administering an effective amount of anti-rubeola antibody.
A method of treating the symptoms of multiple sclerosis comprising the step of administering an effective amount of anti-rubeola antibody.
A method of treating the symptoms of a disease state selected from the group consisting of attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD) comprising the step of administering an effective amount of anti-rubeola antibody.
A dosage unit of pharmaceutical composition for administration to a subject for treatment of a disease state selected from the group consisting of autism, multiple sclerosis, attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD) comprising anti-rubeola antibody in an amount effective to alleviate one or more symptoms of a disease state selected from the group consisting of autism, multiple sclerosis, attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD);
- wherein said amount of anti-rubeola antibody is a single dose between 0.1 mg and 10 mg.
Dependencies are inferred from the claim text.